Regulations

Facilitating implementation of organs-on-chips by open platform technology

Introduction Many Organ-on-Chip platforms are still not robust for all cell types, are not reproducible from experiment to experiment or…

4 years ago

Cherry Biotech comments on FDA Type 2 Diabetes Mellitus: Evaluating the Safety of New Drugs for Improving Glycemic Control Guidance for Industry

What is it? FDA regulations Type 2 Diabetes The purpose of this guidance is to provide the Food and Drug…

4 years ago